Skip to content

Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis

Prospective, Controlled Three-Armed Study About Effectiveness and Compatibility of Silver-Containing Textiles for Treatment of Acute Neurodermatitis

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00196430
Enrollment
32
Registered
2005-09-20
Start date
2004-01-31
Completion date
2004-08-31
Last updated
2005-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodermatitis

Brief summary

The purpose of this study is to investigate whether the treatment of acute neurodermitis with silver-contained textiles is equivalent or more effective to the conservative exogenous treatment with a corticosteroid. Secondary aim is to define skin comfortability of the textiles.

Interventions

DEVICEsilver-contained textiles
DRUGcorticosteroid

Sponsors

Julius Zorn GmbH, Aichach, Germany
CollaboratorUNKNOWN
University Medicine Greifswald
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
2 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of acute Neurodermitis * Age: 2-70 years * Patients are mobile * Patient's information and willingness to participate

Exclusion criteria

* Acute viral infection (herpes zoster, eczema herpeticum) * Acute staphylodermas * Other skin-diseases affecting outcomes of intervention (e.g. psoriasis) * Current UV-Treatment * Current other immunosuppressive or immunomodulated Therapy * Current antimicrobial Therapy (e.g. antibiotics) * Severe general diseases (e.g. melanoma, renal insufficiency, autoimmune diseases) * Pregnancy * Fertile females without effective contraception

Design outcomes

Primary

MeasureTime frame
SCORAD at days -3,0,7,14,28,56 for every group

Secondary

MeasureTime frame
Influence of silver containing textiles in reducing bacterial skin colonization (especially Staph. aureus)
Consumption of corticosteroids at days 0-28
Consumption of corticosteroids at days 28-56
Pruritus under textiles
Evaluation of quality of life

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026